Learn more about FDA-approved AURYXIA® (ferric citrate), iron deficiency anemia (IDA) and hyperphosphatemia (HP).

Feb 18, 2024 · Auryxia: side effects, dosage, interactions, FAQs, reviews. Used for: hyperphosphatemia of renal failure, iron deficiency anemia

Find patient medical information for Auryxia oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Choose the indication you are prescribing for and learn what AURYXIA can do for your patients. Read Important Safety Information and Prescribing Information on this page.

AURYXIA is an iron-based phosphate binder tablet that doesn’t require chewing. In a clinical study, AURYXIA helped people lower their phosphorus levels toward the normal range.

Feb 5, 2024 · Auryxia (ferric citrate) is a phosphate binder used for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. What Are Side Effects of Auryxia? Common side effects of Auryxia include: dark stools (related to the iron content). Seek medical care or call 911 at once if you have the following serious side effects:

Dec 4, 2024 · AURYXIA (ferric citrate) tablets, for oral ... 1.1 Hyperphosphatemia in Chronic Kidney Disease on Dialysis - Auryxia is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on ...

AURYXIA ® (ferric citrate) is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. To report suspected adverse reactions, contact Akebia Therapeutics, Inc. at 1-844-445-3799. Please see full Prescribing Information. AURYXIA ® [Package Insert]. Cambridge, MA: Akebia Therapeutics, Inc.

Dec 4, 2024 · Detailed dosage guidelines and administration information for Auryxia (ferric citrate). Includes dose adjustments, warnings and precautions.

AURYXIA is a prescription medicine that can lower the amount of phosphate in the blood for adults with chronic kidney disease (CKD) who ARE on dialysis. Who should not take …